20.12.2021 22:31:02
|
New Zealand Authorities Link 26-year-old Man's Death To Pfizer's Covid Vaccine
(RTTNews) - New Zealand authorities on Monday said they had linked a 26-year-old man's death to Pfizer's (PFE) Covid-19 vaccine after the man died probably due to myocarditis after taking his first dose.
This is the second death in New Zealand that has been linked to a known but rare side effect from the vaccine. In August, a woman had died after taking the vaccine.
"With the current available information, the board has considered that the myocarditis was probably due to vaccination in this individual," a Covid-19 Vaccine Independent Safety Monitoring Board said in a statement.
"There were no reported symptoms prior to the vaccine and the symptoms of myocarditis developed in the days immediately following his first vaccine dose," the statement added.
The man also did not seek any medical advice or treatment for his symptoms. Myocarditis is an inflammation of the heart muscle that can limit the organ's ability to pump blood and can cause changes in heartbeat rhythms. Myocarditis is a treatable condition, if identified, and outcomes are better the earlier that treatment is started.
Moving ahead, the New Zealand authorities said that "the circumstances of these cases do not impact or change the known information on myocarditis, and the benefits of vaccination with the Pfizer vaccine for COVID-19 continue to greatly outweigh the risk of such rare side effects."
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pfizer Inc.mehr Nachrichten
17.12.24 |
Dienstagshandel in New York: S&P 500 präsentiert sich zum Handelsende leichter (finanzen.at) | |
17.12.24 |
Pfizer-Aktie legt zu: Pfizer prognostiziert für 2025 konstante Umsätze (dpa-AFX) | |
17.12.24 |
Börse New York: S&P 500 liegt nachmittags im Minus (finanzen.at) | |
17.12.24 |
Schwacher Handel: S&P 500 liegt im Minus (finanzen.at) | |
17.12.24 |
S&P 500-Wert Pfizer-Aktie: So viel Verlust hätte eine Pfizer-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
17.12.24 |
NYSE-Handel S&P 500 beginnt die Dienstagssitzung in der Verlustzone (finanzen.at) | |
10.12.24 |
S&P 500-Wert Pfizer-Aktie: So viel Verlust hätte eine Pfizer-Investition von vor 5 Jahren eingebracht (finanzen.at) | |
03.12.24 |
S&P 500-Wert Pfizer-Aktie: So viel hätten Anleger mit einem Investment in Pfizer von vor 3 Jahren verloren (finanzen.at) |
Analysen zu Pfizer Inc.mehr Analysen
19.12.24 | Pfizer Neutral | UBS AG | |
17.12.24 | Pfizer Buy | Jefferies & Company Inc. | |
17.12.24 | Pfizer Neutral | UBS AG | |
17.12.24 | Pfizer Neutral | JP Morgan Chase & Co. | |
12.12.24 | Pfizer Neutral | JP Morgan Chase & Co. |